Stakeholders
Stakeholder Engagement
The Company's operations and services are closely interlinked with stakeholders, whose concerns and degree of attention may directly influence the Company’s development strategies and goal setting. Thus, Changguang highly values and actively implements stakeholder engagement.
The Company follows the five core principles of the AA1000 Stakeholder Engagement Standard (SES)—Influence, Responsibility, Dependency, Tension, and Diverse Perspectives—to examine its operational activities. By referencing the stakeholder identification practices of peer companies in the biotech and healthcare industries, Changguang has identified five primary stakeholder categories: Customers, Employees, Government Agencies, Shareholders, and Suppliers.
The Company has established various communication channels tailored to each stakeholder group based on their specific concerns and the intended purpose of engagement. An annual report on stakeholder communication is submitted to the Chairman.
| Stakeholder | Significance to the Company | Key Issues of Concern | Communication Channels | Frequency | Communication Outcomes & Responses |
|---|---|---|---|---|---|
| Customers | Customers are crucial partners in the Company’s growth. Providing safe, trustworthy, and satisfactory products and services is a core commitment, achieved through continuous innovation and collaborative efforts to enhance competitiveness. | - Product responsibility and safety - Product quality & recall mechanisms - Affordability and pricing - Product innovation and R&D - Financial performance - Ethical operations and regulatory compliance | - Customer satisfaction surveys - Local business visits - Online meetings - On-site customer visits - Participation in international trade shows - Email communication | - Satisfaction survey: Annually - Local visits: 1–2 times/year for Japan, Korea, China; every 2 years for other regions - Online meetings: At least 1–2 times/year - Customer visits: At least once/year for Japan and Korea - Trade shows: 1–2 events/year, varies by region - Email: Real-time | 1. Annual customer satisfaction survey 2. On-site visits and engagement with key customers 3. Virtual meetings for issue-specific updates 4. Participation in major global medical exhibitions (e.g., Medica in Germany, Arab Health in Dubai, FIME in the USA, Hospitalar in Brazil) 5. Prompt responses and regular check-ins via email |
| Employees | Employees are the Company’s most valuable asset. The Company is committed to attracting, nurturing, and retaining talent, while fostering a respectful, safe, and stable work environment where employees can thrive. | - Product responsibility and safety - Business integrity and regulatory compliance - Product quality and recall mechanisms - Energy and greenhouse gas management - Waste management - Financial performance | - Internal announcements - Labor-management meetings - Facility meetings - Department head meetings - Executive meetings - Employee suggestion mailbox | - Internal announcements: 37 annually - Labor-management: Quarterly - Facility: Weekly (40/year) - Dept. head: Weekly (38/year) - Executive: Monthly (12/year) - Suggestion box: Open anytime | 1. Timely announcements and internal communications 2. Active labor-management dialogue 3. Weekly meetings to address plant operations and issues 4. Leadership alignment via monthly executive meetings 5. Open platform for employee feedback |
| Government Agencies | The Company complies with all government regulations, proactively supports policy implementation, and maintains transparent two-way communication to build trust, secure cooperation, and ensure awareness of regulatory changes. | - Product responsibility and safety - Ethical operations and regulatory compliance - Product quality and recall mechanisms - Waste management - Energy and greenhouse gas management | - Official correspondence - Regulatory briefings - Public consultation meetings - Announcement on MOPS - Online submission systems | - Correspondence: Avg. 29/month (MOHW: 40/year) - Briefings: 8/year - Forums: 3/year - MOPS announcements: 10/year - Regulatory submissions (e.g., Taiwan FDA, NHIA, US FDA): Various, as needed | 1. Close communication with Taiwan FDA, NHIA, and international regulators (e.g., US FDA, UK MHRA) 2. Active participation in regulatory forums and guidance meetings 3. Real-time updates on MOPS 4. Regular submission of product registrations and quality documents through digital platforms |
| Shareholders | Shareholders and investors are critical pillars for sustainable growth and value creation. The Company ensures transparency in disclosing management strategies and financial policies to gain their trust and support. | - Product responsibility and safety - Product quality and recall mechanisms - Financial performance - Talent attraction and retention - Product innovation and R&D - Risk and crisis management - Ethical operations and regulatory compliance | - Annual general meeting (AGM) - Annual and semi-annual financial reports - MOPS announcements - Investor relations contact window | - AGM: Annually - Financial reports: Semi-annually - Disclosures: Real-time - Investor contact: Ongoing | 1. Issued financial reports twice annually 2. Held one shareholders’ meeting annually 3. Published 10 material announcements on MOPS 4. Maintained open investor communication through dedicated IR channels |
| Suppliers | Suppliers are key strategic partners. The Company fosters fair and transparent cooperation to build mutual trust and long-term relationships. | - Product responsibility and safety - Ethical operations and regulatory compliance - Product quality and recall mechanisms - Information security and data protection - Supply chain management | - Quotations - Purchase orders - Qua |